(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COMBINING TO CURE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

COMBINING TO CURE

ST13

US500000088802285

Class

35, 41, 42

Filing

88802285

Registration

6262967

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

05/23/2026

Trademark type

Word

Nice classes

35, 41, 42

Filing date

02/19/2020

Registration date

02/02/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/02/2021

Last transaction

05/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/01/2020

First use in commerce

06/01/2020

Drawing code

4

Owner type

03

Owner location

Hayward, CA, US

Examiner

CANTOR, JILLIAN REDDING

Law office

P10

Current location

TMO LAW OFFICE 137

Holders and representatives

Holders

Arcus Biosciences, Inc.

Representatives

B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Technical classification

Nice Classes

Class 35Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Promoting collaboration within the scientificresearchmedical communities to achieve advancements in the field of healthcare and cancer immunotherapy

Class 41

Educational servicesproviding seminarslecturespanel discussionsworkshops and conferences in the field of medicinesciencecancer immunotherapy; Educational servicesproviding educational symposiaeducational events in the nature of seminarslecturespanel discussionsworkshops and conferences in the fields of medicinesciencecancer immunotherapyproviding a website featuring educational resources in the nature of non-downloadable pamphletsinsertsbookletsbrochuresvideosbooksarticlesall in the fields of medicinesciencecancer immunotherapy

Class 42

Research and development services in the fields of medicinepharmaceutical sciencebiotechnologycancer immunotherapy; Research and development servicesdiscovery and clinical development of investigational products in the fields of medicinesciencecancer immunotherapy

Publications

History of USPTO decisions and trademark events.

42 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/21/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/21/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/21/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/21/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/21/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/02/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/14/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/14/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/14/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/03/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/03/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/03/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/15/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/15/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/15/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/15/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/15/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/15/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

02/02/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/31/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/30/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/11/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/11/2020

IUAF

USE AMENDMENT FILED

12/02/2020

EISU

TEAS STATEMENT OF USE RECEIVED

12/02/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/18/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/23/2020

PUBO

PUBLISHED FOR OPPOSITION

06/23/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/03/2020

ALIE

ASSIGNED TO LIE

05/21/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/14/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

05/13/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/13/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

05/13/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/13/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

05/11/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/11/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

05/11/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/11/2020

DOCK

ASSIGNED TO EXAMINER

05/08/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/24/2020

NWAP

NEW APPLICATION ENTERED

02/22/2020

Continuous trademark protection

Get notified about every new filing that threatens COMBINING TO CURE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.